These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17914190)

  • 1. Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.
    Mitsuda Y; Planque S; Hara M; Kyle R; Taguchi H; Nishiyama Y; Paul S
    Mol Biotechnol; 2007 Jun; 36(2):113-22. PubMed ID: 17914190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
    Planque S; Mitsuda Y; Taguchi H; Salas M; Morris MK; Nishiyama Y; Kyle R; Okhuysen P; Escobar M; Hunter R; Sheppard HW; Hanson C; Paul S
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1541-54. PubMed ID: 18160012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and nurture of catalytic antibodies.
    Paul S; Planque SA; Nishiyama Y; Hanson CV; Massey RJ
    Adv Exp Med Biol; 2012; 750():56-75. PubMed ID: 22903666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant domain-regulated antibody catalysis.
    Sapparapu G; Planque S; Mitsuda Y; McLean G; Nishiyama Y; Paul S
    J Biol Chem; 2012 Oct; 287(43):36096-104. PubMed ID: 22948159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.
    Bowen A; Wear MP; Cordero RJ; Oscarson S; Casadevall A
    J Biol Chem; 2017 Jan; 292(2):417-434. PubMed ID: 27872188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why specific anti-integrase antibodies from HIV-infected patients can efficiently hydrolyze 21-mer oligopeptide corresponding to antigenic determinant of human myelin basic protein.
    Odintsova ES; Dmitrenok PS; Timofeeva AM; Buneva VN; Nevinsky GA
    J Mol Recognit; 2014 Jan; 27(1):32-45. PubMed ID: 24375582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural catalytic antibodies.
    Paul S
    Mol Biotechnol; 1996 Jun; 5(3):197-207. PubMed ID: 8837026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic heterogenity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus.
    Andrievskaya OA; Buneva VN; Naumov VA; Nevinsky GA
    Med Sci Monit; 2000; 6(3):460-70. PubMed ID: 11208354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjögren's syndrome.
    Iwasaki K; Okawa-Takatsuji M; Aotsuka S; Ono T
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):346-54. PubMed ID: 14752936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis: Enzymatic Cross Site-Specific Hydrolysis of H1 Histone by IgGs against H1, H2A, H2B, H3, H4 Histones, and Myelin Basic Protein.
    Nevinsky GA; Baranova SV; Buneva VN; Dmitrenok PS
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.
    Kubagawa H; Bertoli LF; Barton JC; Koopman WJ; Mestecky J; Cooper MD
    J Immunol; 1987 Jan; 138(2):435-9. PubMed ID: 3794339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.
    Odintsova ES; Baranova SV; Dmitrenok PS; Calmels C; Parissi V; Andreola ML; Buneva VN; Nevinsky GA
    J Mol Recognit; 2012 Apr; 25(4):193-207. PubMed ID: 22434709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
    Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
    J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
    Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
    Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.
    Kobayashi K; Fujiyama Y; Hagiwara K; Kondoh H
    Microbiol Immunol; 1987; 31(11):1097-106. PubMed ID: 3127662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.